This overview covers the main reasons to avoid them, drawing from Australian guidelines and studies, plus what to do if you're unsure
The primary risks include increased hypoglycemia risk (especially with insulin or sulfonylureas), additive gastrointestinal symptoms such as nausea and diarrhea, and unknown effects on medication absorption due to tirzepatide's delayed gastric emptying
COVID-19 appears to alter glutathione generation patterns related to aging, with younger individuals displaying signs of oxidative damage typically seen in older age groups
According to the Wegovy product information, if you miss two or more consecutive doses, you may either resume at your current dose or your clinician might consider reinitiating the dose-escalation schedule to reduce gastrointestinal side effects
Retrieved October 25, 2017
(XLSX) Abbreviations FGF21: fibroblast growth factor 21 NASH: nonalcoholic steatohepatitis Declarations Funding None to declare